Seegene
Seegene Inc is a South Korean molecular diagnostics biotechnology enterprise specializing in multiplex real-time PCR technologies. The company develops, manufactures, and markets diagnostic assays, automated testing platforms, and reagent kits capable of detecting multiple target pathogens simultaneously. Main revenue drivers consist of sales of molecular diagnostic reagent kits, automated liquid handling hardware, and diagnostic software licensing. Seegene serves hospital clinical laboratories, public health agencies, commercial diagnostic centers, and medical research institutes globally. The company occupies a market-leading position in multiplex PCR testing for infectious diseases, respiratory illnesses, and oncology diagnostics. Headquartered in Seoul, South Korea, Seegene Inc is listed on the KOSDAQ market.
3 of the funds FundTelligence covers report a position in Seegene.
- Legal name
- Seegene Inc
- Sector
- Health Care
- Country
- South Korea
- Funds holding it
- 3
Funds holding Seegene
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.08 % (full portfolio disclosed, October 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.01 % (full portfolio disclosed, October 2026)
- Storebrand Indeks Nye Markeder — Storebrand · 0.0 % (full portfolio disclosed, October 2026)